Skip to main content

Glioblastomas: Role of CXCL12 Chemokine

  • Chapter
  • First Online:
Tumors of the Central Nervous System, Volume 1

Part of the book series: Tumors of the Central Nervous System ((TCNS,volume 1))

  • 1828 Accesses

Abstract

Chemokines are small pro-inflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors on the plasma membrane of target cells. They are also the major regulators of cell trafficking. Chemokines and their receptors were initially associated with the trafficking of leukocytes during physiological immune surveillance and with inflammatory cell recruitment in different diseases. CXCL 12, an alpha-chemokine that binds to G-protein-coupled CXCR4, plays an important and unique role in the regulation of stem/progenitor cell trafficking. Since CXCR4 is expressed on several tumor cells, these CXCR4-positive tumor cells may metastasize to organs that secrete/express CXCL12. In the specific case of gliomas, recent data show that CXCR4 and CXCL12 mRNAs colocalize to glioblastomas and that their expression increases with tumor grade and is associated with regions of necrosis and angiogenesis. This chapter summarises our current knowledge regarding the role of the CXCL12/CXCR4 axis in the central nervous system, focusing on the molecular mechanism by which the CXCL12/CXCR4 axis functions in the accelerated growth of glioblastomas, and further introduces the potential role of CXCL12/CXCR4-targeting compounds for the treatment of glioblastomas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T, Schettini G (2001) Stromal cell-derived factor-1 alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases ½ pathway. J Neurochem 77:1226–1236

    Article  PubMed  CAS  Google Scholar 

  • Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T, Schettini G (2003) Stromal cell-derived factor 1 alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinase ½ and Akt1. Cancer Res 63:1969–1974

    PubMed  CAS  Google Scholar 

  • Brat DJ, Van Meir EG (2004) Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma. Lab Invest 84:397–405

    Article  PubMed  CAS  Google Scholar 

  • Burger JA, Bürkle A (2007) The CXCR4 chemokine receptor in acute and chronic leukeamia: a marrow homing receptor and potential therapeutic target. Br J Haematol 137:288–296

    Article  PubMed  CAS  Google Scholar 

  • Ehtesham M, Mapara. KY, Stevenson CB, Thompson RC (2009) CXCR4 mediates the proliferation of glioblastoma progenitor cells. Cancer Lett 274:305–312

    Article  PubMed  CAS  Google Scholar 

  • Jiang Y, Wu X-H, Shi B, Wu W-X, Yin G-R (2006) Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 103:226–233

    Article  PubMed  CAS  Google Scholar 

  • Kleihues P, Burger PC, Aldape KD, Brat DJ, Biernat W, Bigner DD, Nakazato Y, Plate KH, Giangaspero F, von Deimling A, Ohgaki H, Cavenee WK (2006) Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) Pathology and genetics of tumours of the nervous system. International Agency for Research on Cancer, Lyon, pp 33–52

    Google Scholar 

  • Komatani H, Sugita Y, Arakawa F, Ohshima K, Shigemori M (2009) Expression of CXCL12 on psuedopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. Int J Oncol 34:665–672

    PubMed  CAS  Google Scholar 

  • Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, Emilie D, Terrassa M, Lackner A, Curiel TJ, Carmeliet P, Zou W (2005) CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65:465–472

    PubMed  CAS  Google Scholar 

  • Kucia M, Jankowski. K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ (2004) CXCR4-SDF1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233–245

    Article  PubMed  CAS  Google Scholar 

  • Lazarini F, Than TN, Casanoa P, Arenzana-Seisdedos F, Dubois-Dalcq M (2003) Role of the alpha-chemokine stromal cell-derived factor (SDF1) in the developing and mature central nervous system. Glia 42:139–148

    Article  PubMed  Google Scholar 

  • Li M, Ransohoff RM (2008) Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 84:116–131

    Article  PubMed  CAS  Google Scholar 

  • Liang Z, Brooks J, Willard M, Liang K, Yoon Y, Kang S, Shim H (2007) CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through akt signaling pathway. Biochem Biophys Res Commun 359:716–722

    Article  PubMed  CAS  Google Scholar 

  • Liu XS, Chopp M, Santra M, Hozeska-Solgot A, Zhang RL, Wang L, Teng H, Lu M, Zhang ZG (2008) Functional response to SDF1 alpha through over-expression of CXCR4 on adult subventricular zone progenitor cells. Brain Res 1226:18–26

    Article  PubMed  CAS  Google Scholar 

  • Luo Y, Iathia J, Mughal M, Mattson MP (2008) SDF1alpha/CXCR4 signaling, via ERKs and the transcription factor egr1, induces expression of a 67-kDa form of glutamic acid decarboxylase in embryonic hippocampal neurons. J Biol Chem 283:24789–24800

    Article  PubMed  CAS  Google Scholar 

  • Ma YH, Mentlein R, Knerlich F, Kruse ML, Mehdorn HM, Held-Feindt J (2008) Expression of stem cell markers in human astrocytomas of different WHO grades. J Nerooncol 86:31–45

    Article  Google Scholar 

  • Maderna E, Salmaggi A, Calatozzolo C, Limido L, Pollo B (2007) Nestin, PDGFRbeta, CXCL12, and VEGF in glioma patients: different profiles of (pro-angiogenic) molecule expression are related with tumor grade and May provide prognostic information. Cancer Biol Ther 6:1018–1024

    Article  PubMed  CAS  Google Scholar 

  • Matsuo Y, Ochi N, Sawai M, Yasuda A, Takahashi H, Funahashi H, Takeyama H, Tong Z, Guha S (2009) CXCL8/IL-8 and CXCL12/SDF-1 alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 124:853–861

    Article  PubMed  CAS  Google Scholar 

  • Oh JW, Olman M, Benveniste EN (2009) CXCL12-mediated induction of plasminogen activator inhibitor-1 expression in human CXCR4 positive astroglioma cells. Biol Pharm Bull 32:573–577

    Article  PubMed  CAS  Google Scholar 

  • Ping YF, Yao XH, Chen JH, Liu H, Chen DL, Zhou XD, Wang JM, Bian XW (2007) The anti-cancer compound nordy inhibits CXCR4-mediated production of IL-8 and VEGF by malignant human glioma cells. J Neurooncol 84:21–29

    Article  PubMed  CAS  Google Scholar 

  • Reddy K, Zhou Z, Jia SF, Lee TH, Morales-Arias J, Cao Y, Kleinerman ES (2008) Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing’s sarcoma tumor growth in the absence of vascular endothelial growth factor. Int J Cancer 123:831–837

    Article  PubMed  CAS  Google Scholar 

  • Redjal N, Chan JA, Segal RA, Kung AL (2006) CXCR4 inhibition synergizes with cytotoxic chemotherapy in gliomas. Clin Cancer Res 12:6765–6771

    Article  PubMed  CAS  Google Scholar 

  • Rempel SA, Dudas S, Ge S, Gutiérrez JA (2000) Identification and localization of cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6:102–111

    PubMed  CAS  Google Scholar 

  • Rubin JB, Kung AL, Klein R,S, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster ad, Segal RA (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 100:13513–13518

    Google Scholar 

  • Schönemeier B, Schulz S, Hoellt V, Stumm R (2008) Enhanced expression of the CXCL12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J Neuroimmunol 198:39–45

    Article  PubMed  Google Scholar 

  • Singh, S,, Singh, P,, Grizzle, WE,and, Lillard JW Jr. (2004) CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 84:1666–1676

    Article  PubMed  CAS  Google Scholar 

  • Smith JR, Faikenhagen KM, Coupland SE, Chipps TJ, Rosenblum JT (2007) Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. Am J Clin Pathol 127:633–641

    Article  PubMed  CAS  Google Scholar 

  • Stumm RK, Rummel J, Junker V, Culmsee C, Pfeiffer M, Krieglstein J, HÅ‘llt V, Schulz S (2002) A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 22:5865–5878

    PubMed  CAS  Google Scholar 

  • Sugita Y, Nakamura Y, Yamamoto M, Oda E, Tokunaga O, Shigemori M (2005) Expression of tubulin beta II in neuroepithelial tumors: reflection of architectural changes in the developing human brain. Acta Neuropathol 110:127–134

    Article  PubMed  CAS  Google Scholar 

  • Yang SX, Chen JH, Jiang XF, Wang QL, Chen ZQ, Zhao W, Feng Y-H, Xin R, Shi J-Q, Bian X-W (2005) Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor. Biochem Biophys Res Commun 335:523–528

    Article  PubMed  CAS  Google Scholar 

  • Yang L, Jackson E, Woerner BM, Perry A, Piwnica-Worms D, Rubin JB (2007) Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res 67:651–658

    Article  PubMed  CAS  Google Scholar 

  • Yasumoto K, Koizumi K, Kawashima A, Saitoh Y, Arita Y, Shinohara K, Yamamoto A, Yamamoto H, Miyado K, Okano HJ, Fukagawa R, Higaki K, Minami T, Nakayama T, Sakurai H, Takahashi Y, Yoshie O, Saiki I (2006) Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66:2181–2187

    Article  PubMed  CAS  Google Scholar 

  • Zagzag D, Esencay M, Mendez O, Yee H, Smirnova I, Huang Y, Chiriboga L, Lukyanov E, Liu M, Newcomb EW (2008) Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Schere’s structures. Am J Pathol 173:545–560

    Article  PubMed  CAS  Google Scholar 

  • Zagzag D, Lukyanov Y, Lan Li, Ali MA, Esencay M, Mendez O, Yee H, Voura EB, Newcomb EW (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86:1221–1232

    Article  PubMed  CAS  Google Scholar 

  • Zhang J, Sarkar S, Yong VW (2005) The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis 26:2069–2077

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yasuo Sugita .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Sugita, Y. (2011). Glioblastomas: Role of CXCL12 Chemokine. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 1. Tumors of the Central Nervous System, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0344-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-0344-5_15

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-0343-8

  • Online ISBN: 978-94-007-0344-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics